alexa Leptospirosis | Spain| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences
  • 13th World Congress on Virology
    September 26-27, 2018 Montreal, Canada

Relevant Topics

Leptospirosis

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Leptospirosis

    Pathophysiology: Leptospirosis is a type of bacterial infection spread by animals. It's caused by a strain of bacteria called leptospira. Leptospirosis is a bacterial disease that affects both humans and animals. The early stages of the disease may include high fever, severe headache, muscle pain, chills, redness in the eyes, abdominal pain, jaundice, haemorrhages in skin and mucous membranes (including pulmonary bleeding), vomiting, diarrhoea and a rash. Leptospiral infection in humans causes a range of symptoms, and some infected persons may have no symptoms at all.

  • Leptospirosis

    Treatment: Effective antibiotics include penicillin G, ampicillin, amoxicillin and Doxycycline. In more severe cases cefotaxime or ceftriaxone should be preferred.Glucose and salt solution infusions may be administered; dialysis is used in serious cases. Elevations of serum potassium are common and if the potassium level gets too high special measures must be taken. Serum phosphorus levels may likewise increase to unacceptable levels due to renal failure.

  • Leptospirosis

    Statistics: The mean age was 43.1 ± 13.8 years (84.9% males). The mean annual incidence was 1.99/100.000. There were activities of risk in 94%: 82.5% contact with animals (57.4% pigs, 38.1% dogs, 31.7% cows, 22.2% sheeps), and 31.7% contact with pooled water. The most frequent symptoms were fever (94.1%), arthromyalgias (60.7%), and cephalalgia (53.3%). The main laboratory alterations were hypertransaminemia (48%), renal insufficiency (26.3%), and thrombocytopenia (16.9%).

 

High Impact List of Articles

Conference Proceedings